Basic information Safety Supplier Related

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

Basic information Safety Supplier Related

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Basic information

Product Name:
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
Synonyms:
  • Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
  • N4-Benzoyl-5’-O-(4,4’-dimethoxy trityl)-2’-O,4’-C-methylene-cytidine 3’-O-[(2-cyanoethyl) (N,N-diisopropyl)]-phosphorramidite
  • DMTr-LNA-C(Bz)-3-CED-phosphoramidite
  • N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylene-cytidine?3’-O-[(2-cyanoethyl)?(N,N-diisopropyl)]-phosphoramidite
  • DMTr-L-C(Bz)-3-CED-phosphoramidite
  • N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
  • DMT-2’-0-4’-C-Locked-C(Bz)-Phosphoramidite
  • N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzam
CAS:
206055-78-9
MF:
C47H52N5O9P
MW:
861.93
Mol File:
206055-78-9.mol
More
Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Chemical Properties

pka
8.57±0.20(Predicted)
More
Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Usage And Synthesis

Uses

DMTr-LNA-C(Bz)-3-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

References

[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)Supplier

Nanjing Baifuli Technology Co., Ltd.
Tel
25-25-58740604 15951658055
Email
sales@unisyn.cn
Zhengzhou Granlen Sciences, ltd.
Tel
0371-85513397 +86-18610099868
Email
info@granlen.com
NewCan Biotech Limited
Tel
+86-0571-86912261 +8613735419629
Email
sales@newcanbio.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Beijing Qinling Pharmaceutical Co., Ltd.
Tel
010-61241352 18901327973
Email
834537306@qq.com
More
Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)(206055-78-9)Related Product Information